CHICAGO, Illinois, May 2 -- Rush University Medical Center issued the following news release: A very high level of a protein known as suPAR in the blood of patients with COVID-19 may be a predictor of severe respiratory failure, according to new research published in the Journal of Critical Care on April 30. The findings by researchers at Rush University Medical Center and other institutions suggest suPAR could be a potential predictor for which patients with COVID-19 will need to be put on ven  more

BOSTON, Massachusetts, May 1 -- The Institute for Clinical and Economic Review issued the following announcement: The Institute for Clinical and Economic Review (ICER) released the results of its initial analyses to inform public debate of pricing for remdesivir (Gilead Sciences) and other future treatments of COVID-19. Working with external academic partners, ICER has developed ICER-COVID models comprising two alternative pricing paradigms for COVID-19 treatments: 1) "cost recovery" for the ma  more

NEW YORK, May 2 -- NYU Langone Health, an academic medical center affiliated with New York University, issued the following news release: Despite concerns expressed by some experts, common high blood pressure medications did not increase the risk of contracting 2019 coronavirus disease (COVID-19)--or of developing severe disease--in a study of 12,594 patients. Published online May 1 in the New England Journal of Medicine, the study was launched in response to a March 17 joint statement issued   more